atropine has been researched along with pexacerfont in 1 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (pexacerfont) | Trials (pexacerfont) | Recent Studies (post-2010) (pexacerfont) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 13 | 5 | 8 |
| Protein | Taxonomy | atropine (IC50) | pexacerfont (IC50) |
|---|---|---|---|
| Substance-K receptor | Homo sapiens (human) | 4.9 | |
| Corticotropin-releasing factor receptor 1 | Homo sapiens (human) | 0.1169 | |
| Corticotropin-releasing factor receptor 1 | Rattus norvegicus (Norway rat) | 0.0368 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arneric, SP; Bai, S; Clarke, T; Fitzgerald, L; Gilligan, PJ; Grossman, S; Hartig, P; He, L; Heman, K; Krause, C; Lelas, S; Li, YW; Marshall, A; McElroy, JF; Miller, K; Robertson, D; Saye, J; Trainor, G; Ward, K; Wong, H; Zaczek, R; Zeller, K; Zhang, G | 1 |
1 other study(ies) available for atropine and pexacerfont
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of 8-(pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonists.
Topics: Administration, Oral; Animals; Behavior, Animal; Biological Availability; Clinical Trials as Topic; Dogs; Inhibitory Concentration 50; Rats; Receptors, Corticotropin-Releasing Hormone; Solubility; Structure-Activity Relationship; Triazines; Water | 2009 |